| Role for neuronal insulin resistance in neurodegenerative diseases M Schubert, D Gautam, D Surjo, K Ueki, S Baudler, D Schubert, T Kondo, ... Proceedings of the National Academy of Sciences 101 (9), 3100-3105, 2004 | 770 | 2004 |
| Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ... Neuro-oncology 18 (9), 1199-1208, 2016 | 753 | 2016 |
| Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a … U Herrlinger, T Tzaridis, F Mack, JP Steinbach, U Schlegel, M Sabel, ... The lancet 393 (10172), 678-688, 2019 | 518 | 2019 |
| Joint EANM/EANO/RANO practice guidelines/SNMMI procedure standards for imaging of gliomas using PET with radiolabelled amino acids and [18F]FDG: version … I Law, NL Albert, J Arbizu, R Boellaard, A Drzezga, N Galldiks, ... European journal of nuclear medicine and molecular imaging 46, 540-557, 2019 | 486 | 2019 |
| Advances in neuro-oncology imaging KJ Langen, N Galldiks, E Hattingen, NJ Shah Nature Reviews Neurology 13 (5), 279-289, 2017 | 367 | 2017 |
| Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice MT Heneka, M Ramanathan, AH Jacobs, L Dumitrescu-Ozimek, ... Journal of Neuroscience 26 (5), 1343-1354, 2006 | 355 | 2006 |
| EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours E Le Rhun, M Guckenberger, M Smits, R Dummer, T Bachelot, F Sahm, ... Annals of Oncology 32 (11), 1332-1347, 2021 | 346 | 2021 |
| 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors AH Jacobs, A Thomas, LW Kracht, H Li, C Dittmar, G Garlip, N Galldiks, ... Journal of Nuclear Medicine 46 (12), 1948-1958, 2005 | 314 | 2005 |
| Diagnosis of pseudoprogression in patients with glioblastoma using O-(2-[18F]fluoroethyl)-l-tyrosine PET N Galldiks, V Dunkl, G Stoffels, M Hutterer, M Rapp, M Sabel, ... European journal of nuclear medicine and molecular imaging 42, 685-695, 2015 | 267 | 2015 |
| Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ... Neuro-oncology 18 (11), 1529-1537, 2016 | 228 | 2016 |
| Assessment of treatment response in patients with glioblastoma using O-(2-18F-fluoroethyl)-L-tyrosine PET in comparison to MRI N Galldiks, KJ Langen, R Holy, M Pinkawa, G Stoffels, KW Nolte, ... Journal of Nuclear Medicine 53 (7), 1048-1057, 2012 | 219 | 2012 |
| Role of O-(2-18F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis N Galldiks, G Stoffels, CP Filss, MD Piroth, M Sabel, MI Ruge, H Herzog, ... Journal of Nuclear Medicine 53 (9), 1367-1374, 2012 | 217 | 2012 |
| Diagnostic performance of 18F-FET PET in newly diagnosed cerebral lesions suggestive of glioma M Rapp, A Heinzel, N Galldiks, G Stoffels, J Felsberg, C Ewelt, M Sabel, ... Journal of nuclear medicine 54 (2), 229-235, 2013 | 213 | 2013 |
| The use of dynamic O-(2-18F-fluoroethyl)-l-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma N Galldiks, G Stoffels, C Filss, M Rapp, T Blau, C Tscherpel, G Ceccon, ... Neuro-oncology 17 (9), 1293-1300, 2015 | 211 | 2015 |
| PET imaging in patients with meningioma—report of the RANO/PET Group N Galldiks, NL Albert, M Sommerauer, AL Grosu, U Ganswindt, I Law, ... Neuro-oncology 19 (12), 1576-1587, 2017 | 209 | 2017 |
| Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-l-tyrosine PET in comparison to MRI N Galldiks, M Rapp, G Stoffels, GR Fink, NJ Shah, HH Coenen, M Sabel, ... European journal of nuclear medicine and molecular imaging 40, 22-33, 2013 | 194 | 2013 |
| PET imaging in patients with brain metastasis—report of the RANO/PET group N Galldiks, KJ Langen, NL Albert, M Chamberlain, R Soffietti, MM Kim, ... Neuro-oncology 21 (5), 585-595, 2019 | 181 | 2019 |
| Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy G Ceccon, P Lohmann, G Stoffels, N Judov, CP Filss, M Rapp, E Bauer, ... Neuro-oncology 19 (2), 281-288, 2017 | 164 | 2017 |
| Diagnostic challenges in meningioma M Nowosielski, N Galldiks, S Iglseder, P Kickingereder, A Von Deimling, ... Neuro-oncology 19 (12), 1588-1598, 2017 | 163 | 2017 |
| From the clinician's point of view-What is the status quo of positron emission tomography in patients with brain tumors? N Galldiks, KJ Langen, WB Pope Neuro-oncology 17 (11), 1434-1444, 2015 | 162 | 2015 |
Karl-Josef LangenVerified email at fz-juelich.de
